Login

Watch NRG Energy CEO Mauricio Gutierrez discuss #EmbracingSustainability at NRG and challenge Steve Mollenkopf to share their sustainability efforts. 00:10:00

Share On Facebook Share On Twitter

Mauricio Gutierrez, CEO of NRG Energy

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Mastering Super Payments: How to Maximize Your Benefits with AustralianSuper's Business Portal
00:10:00
Addressing Structural Racism in Healthcare through Innovative Technology Solutions | Andrew Toy, CEO, Clover Health Investments Corp.
00:10:00
Current Trends and Future Prospects in the European Fundraising Market: A Conversation with Gordon Binet | Gordon Bajnai, Chairman , Campbell Lutyens.
00:10:00
Calfrac Well Services - 20th Anniversary message from Ron Mathison | Pat Powell, CEO, Calfrac Well Services LtdCFW:TOR
00:00:00
BioPorto discusses 'fantastic first half of the year' driven by antibodies and RUO NGAL Test sales - Peter Mørch Eriksen, CEO/Board Member,Bioporto
00:00:00
Lionel Segard, CEO of Quantum Genomics
00:10:00
Embracing Sustainability and Shifting Towards Electricity Surplus| Darius Maikštenas, CEO, Ignitis Grupe AB.
00:10:00
Transforming School Districts into Innovative, High-Performance Entities by 2030
00:10:00
NCR Atleos, now an independent company focused on transforming the ATM industry, features CEO Tim Oliver in a conversation with Judy Khan.|Michael D. Hayford Retiring as NCR Chief Executive Officer
00:10:00
Harmonic Inc company culture was rated poorly by employees, with CEO Patrick Harshman receiving an F (56/100), placing him in the bottom 5%.
00:10:00
Izertis CEO Pablo Martín Prepares for Market Leap After Decade of Tenfold Growth | Pablo Martin, CEO, IZERTIS SA.
00:10:00
Meet Jason Gunkel: Syverson Strege Team | Jason Gunkel, Chief Investment Officer, Financial Planner of Syverson Strege

© 2017 - Neuhu+